Overview

  • Product name
    ABT-737
  • Description
    BH3 mimetic Bcl-xL, Bcl-2 and Bcl-w inhibitor
  • Biological description
    BH3 mimetic Bcl-xL, Bcl-2 and Bcl-w inhibitor. Triggers Bax/Bak-mediated apoptosis (EC50 values are 79, 30 and 198 nM for Bcl-xL, Bcl-2 and Bcl-w mediated apoptosis respectively). Shows antitumor effects in vivo.
  • Purity
    > 95%

Properties

References

This product has been referenced in:
  • Yang MC  et al. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: A prospective combination of ABT-737 and TMZ for treating glioma. Int J Oncol : (2015). Read more (PubMed: 25586056) »
  • Gu D  et al. Inhibition of the MDM2 E3 Ligase induces apoptosis and autophagy in wild-type and mutant p53 models of multiple myeloma, and acts synergistically with ABT-737. PLoS One 9:e103015 (2014). Read more (PubMed: 25181509) »
  • van Delft MF  et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10:389-99 (2006). Read more (PubMed: 17097561) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab141336.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up